NCT05197348

Brief Summary

The aim of this study is to verify the efficacy of the Spanish adaptation of Meaning-Centered Psychotherapy for Spanish participants with cancer in a randomized control trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Jan 2021

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 2, 2021

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 4, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 19, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

May 26, 2026

Status Verified

December 1, 2022

Enrollment Period

2.2 years

First QC Date

January 4, 2022

Last Update Submit

May 21, 2026

Conditions

Keywords

Meaning Centered PsychotherapyCancer survivorsMeaning in LifeCognitive Behavioral TherapyRandomized Control Trial

Outcome Measures

Primary Outcomes (2)

  • Meaning in Life Questionnaire (MLQ)

    The MLQ is a self-reported questionnaire made up of 10 items, and it was developed to assess the two main dimensions of meaning in life: presence and search for meaning in life. The items are rated on a 7-point scale ranging from 1 (absolutely false) to 7 (absolutely true). The factors of Presence and Search were correlated (r = -.19), and internal consistency was good for Presence (.86) and Search (.87). One-month test-retest reliability coefficients were .70 for Presence and .73 for Search.

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

  • The Multidimensional Existential Meaning Scale (MEMS)

    The MEMS assesses the meaning in life dimensions: Comprehension, purpose, and mattering, with a total of 15 items. Likert type responses are given on a 7-point scale (1 = Very strongly disagree; 7 = Very strongly agree). The three MEMS subscales showed adequate internal consistency: Comprehension (ϖ = 91), Purpose (ϖ = 92), and Mattering (ϖ = 86).

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

Secondary Outcomes (8)

  • Overall Anxiety Severity and Impairment Scale (OASIS)

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

  • Overall Depression Severity and Impairment Scale (ODSIS)

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

  • Hopelessness Scale (HS)

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

  • The Positive and Negative Affect Schedule (PANAS)

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

  • Quality of life index-Spanish version (QLI)

    Changes will be assessed from pre-treatment to immediately after the intervention, and also at 6-month follow-up.

  • +3 more secondary outcomes

Study Arms (2)

Meaning-Centered Group Psychotherapy (MCP).

EXPERIMENTAL

The intervention lasts two months and includes eight sessions that follow a two-hour group format on a weekly basis. The investigators will follow the manualized MCP for patients with advanced cancer.

Behavioral: Meaning-Centered Group Psychotherapy (MCP).

Cognitive Behavioral Psychotherapy (CBT).

ACTIVE COMPARATOR

The intervention lasts two months and includes eight sessions that follow a two-hour group format on a weekly basis, with the following sessions. The investigators will follow the manualized CBT or patients with advanced cancer.

Behavioral: Cognitive Behavioral Psychotherapy (CBT).

Interventions

The MCP program is divided into eight sessions: Session1: Psychoeducation about Meaning in life, Sources of Meaning, etc. Session 2: Cancer illness and meaning. Session 3: Historical Sources of Meaning (the past) Session 4: Historical Sources of Meaning (present and future). Session 5: Attitudinal Sources of Meaning. Session 6: Creative Sources of Meaning. Session 7: Experimental Sources of Meaning. Session 8: End of psychotherapy, farewell, and facing the future with hope.

Meaning-Centered Group Psychotherapy (MCP).

The CBT divided into eight sessions: Session1: Presentation of psychotherapy, establishing the goals of psychotherapy. Presentation of the participants. Updated information about psychological consequences of cancer. Session 2. Increase in enjoyable activities. Behavioral activation. Progressive muscle relaxation training. Slow breathing training. Session 3. Cognitive model of coping with cancer. Psychoeducation on negative thoughts. Training in detecting negative thoughts. Presentation of cognitive distortions Session 4. Training in cognitive restructuring techniques. Session 5. Training in problem-solving skills. Session 6. Being aware of participants needs. Self-care. Assertiveness skills training. Session 7. Setting goals for the future. Session 8. Summary, relapse prevention, and end of psychotherapy.

Cognitive Behavioral Psychotherapy (CBT).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Participants will be adults with stage I, II, and III cancer who have completed their medical treatment (surgery, radiotherapy, or chemotherapy).
  • Participants will have to express a need for psychological care.
  • Participants will have low meaning in life.

You may not qualify if:

  • Participants who are currently receiving another psychological or psychiatric treatment.
  • Diagnosis of a serious mental disorder (schizophrenia, substance dependence, dementia, or cognitive impairment).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Valencia

Valencia, Valencia, 46010, Spain

Location

Related Publications (10)

  • Marco JH, Alonso S, Banos R. Meaning-making as a mediator of anxiety and depression reduction during cognitive behavioral therapy intervention in participants with adjustment disorders. Clin Psychol Psychother. 2021 Mar;28(2):325-333. doi: 10.1002/cpp.2506. Epub 2020 Sep 10.

    PMID: 32881109BACKGROUND
  • Breitbart W, Rosenfeld B, Pessin H, Kaim M, Funesti-Esch J, Galietta M, Nelson CJ, Brescia R. Depression, hopelessness, and desire for hastened death in terminally ill patients with cancer. JAMA. 2000 Dec 13;284(22):2907-11. doi: 10.1001/jama.284.22.2907.

    PMID: 11147988BACKGROUND
  • van der Spek N, Vos J, van Uden-Kraan CF, Breitbart W, Cuijpers P, Holtmaat K, Witte BI, Tollenaar RAEM, Verdonck-de Leeuw IM. Efficacy of meaning-centered group psychotherapy for cancer survivors: a randomized controlled trial. Psychol Med. 2017 Aug;47(11):1990-2001. doi: 10.1017/S0033291717000447. Epub 2017 Apr 4.

    PMID: 28374663BACKGROUND
  • Vos J, Vitali D. The effects of psychological meaning-centered therapies on quality of life and psychological stress: A metaanalysis. Palliat Support Care. 2018 Oct;16(5):608-632. doi: 10.1017/S1478951517000931. Epub 2018 Sep 24.

    PMID: 30246682BACKGROUND
  • Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J, Olden M, Pessin H, Lichtenthal W, Sjoberg D, Cassileth BR. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer. J Clin Oncol. 2012 Apr 20;30(12):1304-9. doi: 10.1200/JCO.2011.36.2517. Epub 2012 Feb 27.

    PMID: 22370330BACKGROUND
  • Rosenfeld B, Saracino R, Tobias K, Masterson M, Pessin H, Applebaum A, Brescia R, Breitbart W. Adapting Meaning-Centered Psychotherapy for the palliative care setting: Results of a pilot study. Palliat Med. 2017 Feb;31(2):140-146. doi: 10.1177/0269216316651570. Epub 2016 Jul 21.

    PMID: 27435603BACKGROUND
  • Lichtenthal WG, Catarozoli C, Masterson M, Slivjak E, Schofield E, Roberts KE, Neimeyer RA, Wiener L, Prigerson HG, Kissane DW, Li Y, Breitbart W. An open trial of meaning-centered grief therapy: Rationale and preliminary evaluation. Palliat Support Care. 2019 Feb;17(1):2-12. doi: 10.1017/S1478951518000925. Epub 2019 Jan 26.

    PMID: 30683164BACKGROUND
  • Winger JG, Ramos K, Kelleher SA, Somers TJ, Steinhauser KE, Porter LS, Kamal AH, Breitbart WS, Keefe FJ. Meaning-Centered Pain Coping Skills Training: A Pilot Feasibility Trial of a Psychosocial Pain Management Intervention for Patients with Advanced Cancer. J Palliat Med. 2022 Jan;25(1):60-69. doi: 10.1089/jpm.2021.0081. Epub 2021 Aug 12.

    PMID: 34388037BACKGROUND
  • Marco JH, Llombart P, Romero R, Garcia-Conde A, Corral V, Guillen V, Perez S. Meaning-Centered Psychotherapy Versus Cognitive Behavioral Therapy for Cancer Survivors: A Randomized Controlled Trial☆. Behav Ther. 2024 Sep;55(5):1071-1083. doi: 10.1016/j.beth.2024.03.005. Epub 2024 Apr 10.

  • Marco JH, Llombart P, Guillen V, Banos RM, Romero R, Garcia-Conde A, Perez Rodriguez S. Spanish Adaptation of Meaning-Centered Psychotherapy for Participants With Cancer: Study Protocol of a Randomized Control Trial. Front Psychiatry. 2022 Jul 7;13:892573. doi: 10.3389/fpsyt.2022.892573. eCollection 2022.

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Pilar Llombart, Ph.D.Student

    Valencian Institute of Oncology Foundation (IVO)

    PRINCIPAL INVESTIGATOR
  • Sandra Perez, Ph.D.

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • Veronica Guillen Botella, Ph.D.

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • Joaquin Garcia-Alandete, Ph.D.

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • Rosa Baños, Ph.D.

    University of Valencia

    PRINCIPAL INVESTIGATOR
  • Jose Heliodoro Marco Salvador, Ph. D.

    University of Valencia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Control Trial, efficacy Study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Phychology

Study Record Dates

First Submitted

January 4, 2022

First Posted

January 19, 2022

Study Start

January 2, 2021

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

May 26, 2026

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations